Whitehawk Therapeutics (WHWK) Return on Sales (2018 - 2025)

Whitehawk Therapeutics (WHWK) has 7 years of Return on Sales data on file, last reported at 0.13% in Q4 2025.

• Return on Sales for Q4 2025 came in at 0.13%, up 15.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.13% (up 15.0% YoY), and the FY2025 annual result was 0.03%, changed 0.0% from the prior year.
• Return on Sales grew to 0.13% in Q4 2025 per WHWK's latest filing, from 0.01% in the prior quarter.
• Over five years, Return on Sales peaked at 0.13% in Q4 2025 and troughed at 0.46% in Q1 2021.
• A 5-year average of 0.04% and a median of 0.03% in 2023 frame the typical range for Return on Sales.
• On a YoY basis, Return on Sales climbed as much as 40 bps in 2022 and fell as far as 5 bps in 2022.
• A 5-year view of Return on Sales shows it stood at 0.01% in 2021, then slumped by 133 bps to 0.03% in 2022, then increased by 3 bps to 0.03% in 2023, then increased by 2 bps to 0.03% in 2024, then jumped by 595 bps to 0.13% in 2025.
• Business Quant data shows WHWK's Return on Sales at 0.13% in Q4 2025, 0.01% in Q3 2025, and 0.0% in Q2 2025.